Next, to specifically investigate whether I-NCMs can induce tumor lysis independent of T cells, we pharmacologically depleted CD4+ and CD8+ T cells in Nr4a1–/– mice and evaluated the efficacy of I-NCMs (Figure 7, C and D). The gene discussed is CD8A; the disease is neoplasm.